Remove 2006 Remove Laboratories Remove Testimonials
article thumbnail

Article FDA Thank You Congress prepares to markup pandemic legislation, all but confirming FDA-related provisions won’t advance

Agency IQ

BY LAURA DIANGELO, MPH JUL 12, 2023 7:14 PM CDT Quick background: the Pandemic and All-Hazards Preparedness Act The Pandemic and All-Hazards Preparedness Act (PAHPA) was originally passed in 2006. Congress is already working on the reauthorization process.

FDA 40
article thumbnail

Analysis Life Sciences Thank You Everything the FDA is planning to do in Q3 2023

Agency IQ

A big legislative question about PAHPA Reauthorization : The Pandemic and All-Hazards Preparedness Act (PAHPA) was originally passed in 2006. to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug.

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis Chemical Thank You Overview of the U.S. regulation of PFAS

Agency IQ

The PFAS National Testing Strategy was also released in October 2021 and states that: “PFAS can cause reproductive, developmental, liver, kidney, and immunological toxicity … and produce tumors in laboratory animals. The next round will be reported in from June 1 to September 30, 2024 and will comprise data from 2020, 2021, 2022, and 2023.

article thumbnail

Origins of the Lab Mouse

Codon

These “fancy” varieties were then standardized in the 1920s by a small group of researchers at the Jackson Laboratory in Maine who intended to use them to investigate the genetics of cancer but were instead forced to sell their mice to support the lab when funding dried up during the Great Depression. Image Credit: JAX Handbook.

article thumbnail

Let's Quit Sugar With Audiobook – Let's Quit Sugar

The Pharma Data

Testimonials are not necessarily representative of all of those who will use our products. Some of our testimonials are provided by customers who have received promotional offers in exchange for their participation. The testimonials displayed are given verbatim except for correction of grammatical or typing errors. Stanhope KL.

Disease 52
article thumbnail

50-State Survey of State Court Decisions Supporting Expert-Related Judicial Gatekeeping

Drug & Device Law

We think that they can, and for a state (like Pennsylvania and a number of others) that still follows the “ Frye ” standard looking to the “general acceptance” of expert testimony as the touchstone to admissibility, a Rule 702 state-law equivalent might look something like this: Rule 702. E.g. , Walsh v. BASF Corp. , 3d 446, 461 (Pa.

article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

Wyeth Laboratories, Inc. , Wyeth Laboratories, Inc. , Connaught Laboratories, Inc. Lederle Laboratories , 2008 WL 972657 (W. Lederle Laboratories recognized that courts, generally, are “reluctan[t]. . . 2006), app. 2d 748, 753-54 (Ohio 1988). 2d 397 (6th Cir. Accord Miller v. 1995 WL 579969, at *7 (D.

FDA 59